Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:countryOfOrigin |
gptkb:United_Kingdom
|
| gptkbp:developedBy |
gptkb:Autolus_Therapeutics
|
| gptkbp:drugClass |
gene therapy
|
| https://www.w3.org/2000/01/rdf-schema#label |
AUTO3
|
| gptkbp:intendedUse |
diffuse large B-cell lymphoma
B-cell malignancies |
| gptkbp:mechanismOfAction |
dual targeting of CD19 and CD22 antigens
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:CD22
gptkb:CD19 |
| gptkbp:bfsParent |
gptkb:Autolus_Therapeutics
|
| gptkbp:bfsLayer |
7
|